Literature DB >> 10877922

Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.

J Sautter1, G U Höglinger, W H Oertel, C D Earl.   

Abstract

Cryopreservation may allow long-term storage of embryonic ventral mesencephalon (VM) for neural transplantation. We investigated whether the ganglioside GM1 or the lazaroid tirilazad mesylate (U-74006F) could improve survival of grafts derived from cryopreserved VM in a rat model of Parkinson's disease. VM was dissected from rat embryos (E14-E15), frozen and stored in liquid nitrogen under controlled conditions, thawed, dissociated, and then grafted into the 6-hydroxydopamine-lesioned rat striatum. In Experiment I, VM fragments were exposed in vitro either to GM1 (100 microM) or to lazaroid (0.3 microM) during all preparative steps. In Experiment II, rats receiving GM1-pretreated VM were, in addition, treated systematically with GM1 (30 mg/kg) daily for 3.5 weeks. Rats grafted with untreated cryopreserved or fresh VM were used as controls, respectively. Rats receiving fresh VM control grafts showed complete recovery from lesion-induced rotations after 6 weeks whereas rats grafted with cryopreserved VM (untreated or pretreated) did not recover. Cryografts contained significantly less (18%, control; 23%, GM1; and 12%, lazaroid) tyrosine hydroxylase-positive cells compared to fresh grafts (1415 +/- 153; mean +/- SEM). Graft volume was also significantly smaller after cryopreservation. In contrast, with additional systemic GM1 treatment cryografts contained almost the same number of tyrosine hydroxylase-positive cells (376 +/- 85) as fresh grafts (404 +/- 56), which was significantly more than that of untreated cryografts (147 +/- 20), showed a significantly larger volume (0.15 mm(3)) compared to that of untreated grafts (0.08 mm(3)) (fresh controls, 0.19 mm(3)), and induced significant and complete functional recovery in the rotation test. In conclusion, systemic treatment of rats with GM1 improved the low survival and functional inefficacy of grafts derived from cryopreserved VM whereas tissue pretreatment alone with either GM1 or lazaroid was not effective. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877922     DOI: 10.1006/exnr.2000.7410

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Neuroprotective effect of ganglioside GM1 on the cytotoxic action of hydrogen peroxide and amyloid beta-peptide in PC12 cells.

Authors:  Tatyana V Sokolova; Irina O Zakharova; Victor V Furaev; Maria P Rychkova; Natalia F Avrova
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

2.  Protective and antioxidative effects of GM1 ganglioside in PC12 cells exposed to hydrogen peroxide are mediated by Trk tyrosine kinase.

Authors:  Natalia F Avrova; Tatyana V Sokolova; Yulia A Vlasova; Irina O Zakharova; Victor V Furaev; Maria P Rychkova
Journal:  Neurochem Res       Date:  2009-07-21       Impact factor: 3.996

3.  GM1 ganglioside activates ERK1/2 and Akt downstream of Trk tyrosine kinase and protects PC12 cells against hydrogen peroxide toxicity.

Authors:  Irina O Zakharova; Tatyana V Sokolova; Yulia A Vlasova; Victor V Furaev; Maria P Rychkova; Natalia F Avrova
Journal:  Neurochem Res       Date:  2014-09-13       Impact factor: 3.996

Review 4.  Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases.

Authors:  Jacques Fantini; Nouara Yahi
Journal:  Expert Rev Mol Med       Date:  2010-09-01       Impact factor: 5.600

5.  Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration.

Authors:  Anandh Dhanushkodi; Michael P McDonald
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

Review 6.  Effects of Gangliosides on Spermatozoa, Oocytes, and Preimplantation Embryos.

Authors:  Bo Hyun Kim; Won Seok Ju; Ji-Su Kim; Sun-Uk Kim; Soon Ju Park; Sean M Ward; Ju Hyeong Lyu; Young-Kug Choo
Journal:  Int J Mol Sci       Date:  2019-12-22       Impact factor: 5.923

7.  Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application.

Authors:  Satoe Hiramatsu; Asuka Morizane; Tetsuhiro Kikuchi; Daisuke Doi; Kenji Yoshida; Jun Takahashi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.